Word

STATERA BIOPHARMA

Status

Dead

Status Code

606

Status Date

Monday, January 8, 2024

Serial Number

90844996

Mark Type

3000

Filing Date

Friday, July 23, 2021

Published for Opposition

Tuesday, April 11, 2023

Abandoned Date

Monday, January 8, 2024

Trademark Owner History

Cytocom, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements

42 Medical and pharmaceutical research services; pharmaceutical research and development

The mark consists of eight round dots of two different sizes forming the overall appearance of a diamond shape. Two of the dots are connected by a line. Below the diamond shape are the words "STATERA BIOPHARMA", with the letter "A" stylized. The word "STATERA" appears in larger font than the word "BIOPHARMA". "BIOPHARMA" appears underneath "STATERA".
"BIOPHARMA"

Trademark Events

Jan 8, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 8, 2024

Abandonment - No Use Statement Filed

Jun 6, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 11, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 11, 2023

Published For Opposition

Mar 22, 2023

Notification Of Notice Of Publication E-Mailed

Mar 6, 2023

Approved For Pub - Principal Register

Mar 4, 2023

Teas/Email Correspondence Entered

Mar 3, 2023

Correspondence Received In Law Office

Mar 3, 2023

Teas Request For Reconsideration Received

Dec 8, 2022

Notification Of Final Refusal Emailed

Dec 8, 2022

Final Refusal E-Mailed

Dec 8, 2022

Final Refusal Written

Oct 28, 2022

Teas/Email Correspondence Entered

Oct 27, 2022

Correspondence Received In Law Office

Oct 27, 2022

Teas Response To Office Action Received

Apr 27, 2022

Notification Of Non-Final Action E-Mailed

Apr 27, 2022

Non-Final Action E-Mailed

Apr 27, 2022

Non-Final Action Written

Apr 19, 2022

Assigned To Examiner

Nov 19, 2021

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 19, 2021

Teas Change Of Correspondence Received

Nov 19, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 19, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 19, 2021

Teas Change Of Owner Address Received

Sep 24, 2021

Notice Of Design Search Code E-Mailed

Sep 23, 2021

New Application Office Supplied Data Entered

Jul 27, 2021

New Application Entered